BLISS-BELIEVE study on sequential belimumab and rituximab in SLE reports mixed results but promising disease control benefits
Mycophenolate mofetil reduces severe flares and lower lupus nephritis incidence in patients with early-stage systemic lupus erythematosus
Study reveals CARD9/neutrophil signaling axis as a key driver of IL-17A-mediated ankylosing spondylitis
